Topical RM191A gel for chronic peripheral neuropathic pain: randomized, double-blind, placebo-controlled, crossover pilot study.

Front Pain Res (Lausanne) · 2026 · PMC13066219 · PMID 41970637

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

approached significancep = 0.055so close (0.05 < p ≤ 0.1)

The worst pain score before Treatment Period 1 was 7.9 ± 1.1 which was higher than that before Treatment Period 2 (7.1 ± 1.7), and this difference approached significance ( t = 0.196, p = 0.055). 3.3.2 NPSI The average total NPSI score at the baseline visit was 27 ± 19.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.